Aubrey Rankin, President of Revance Therapeutics and a director of the company, recently acquired 30,000 shares of the company. The buys took place at $14.43 per share, on December 03, 2021. Rankin now owns 571,376 shares of the company. Rankin operates out of Nashville, TN. Some additional info was provided as follows:
The price reported in Table 1, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.33 to $14.50. Mr. Rankin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
These shares are held by The Rank in Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.
These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.